Nano Letters · 2014 · 46 citations · 20 references
PharmacyPharmaceuticsPharmacologyChemotherapyDrug DeliveryNanoparticle Drug DeliveryCancer NanomedicineNanomedicineNanoparticle Delivery SystemsNanoparticle DesignNanoparticle FormulationsPassive TargetingAcid-labile ProdrugsChemotherapy DeliveryDrug Delivery NanocarriersNanoparticle DeliveryNanoparticle-delivered ProdrugsPassive Tumor TargetingProdrug NanoparticlesSmall Molecule Therapeutics
Delivery systems designed to have triggered release after passively targeting the tumor may improve small molecule chemotherapeutic delivery. Particle replication in nonwetting templates was used to prepare nanoparticles to passively target solid tumors in an A549 subcutaneous xenograft model. An acid labile prodrug was delivered to minimize systemic free docetaxel concentrations and improve tolerability without compromising efficacy.
20
William J. Gradishar, Sergei Tjulandin, Neville Davidson et al. · Journal of Clinical Oncology · 2005 · 2.1K citations · Full text
Pharmacy, Oncology, Pharmacology +15
Synthesis and Biological Response of Size-Specific, Monodisperse Drug–Silica Nanoconjugates
Li Tang, Timothy M. Fan, Luke B. Borst et al. · ACS Nano · 2012 · 199 citations · Full text